{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T16:16:14Z","timestamp":1790007374508,"version":"4.0.1"},"reference-count":114,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82160051"],"award-info":[{"award-number":["82160051"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32100908"],"award-info":[{"award-number":["32100908"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020205","name":"Health Commission of Jiangxi Province","doi-asserted-by":"publisher","award":["202311143"],"award-info":[{"award-number":["202311143"]}],"id":[{"id":"10.13039\/501100020205","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011833","name":"Guangxi University of Chinese Medicine","doi-asserted-by":"publisher","award":["2020BSZR009"],"award-info":[{"award-number":["2020BSZR009"]}],"id":[{"id":"10.13039\/501100011833","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011833","name":"Guangxi University of Chinese Medicine","doi-asserted-by":"publisher","award":["jxsq2020101074"],"award-info":[{"award-number":["jxsq2020101074"]}],"id":[{"id":"10.13039\/501100011833","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004479","name":"Natural Science Foundation of Jiangxi Province","doi-asserted-by":"publisher","award":["20212BAB216005"],"award-info":[{"award-number":["20212BAB216005"]}],"id":[{"id":"10.13039\/501100004479","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019037","name":"Key Science and Technology Research Project in Jiangxi Province Department of Education","doi-asserted-by":"publisher","award":["GJJ2200904"],"award-info":[{"award-number":["GJJ2200904"]}],"id":[{"id":"10.13039\/501100019037","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vascular Pharmacology"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.vph.2023.107193","type":"journal-article","created":{"date-parts":[[2023,7,9]],"date-time":"2023-07-09T09:39:06Z","timestamp":1688895546000},"page":"107193","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Cardiovascular aspects of ELABELA: A potential diagnostic biomarker and therapeutic target"],"prefix":"10.1016","volume":"151","author":[{"given":"Chuanming","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.vph.2023.107193_bb0005","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1016\/j.jacc.2019.03.009","article-title":"2019 ACC\/AHA guideline on the primary prevention of cardiovascular disease: executive summary: a report of the American College of Cardiology\/American Heart Association task force on clinical practice guidelines","volume":"74","author":"Arnett","year":"2019","journal-title":"J. Am. Coll. Cardiol."},{"issue":"10159","key":"10.1016\/j.vph.2023.107193_bb0010","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1016\/S0140-6736(18)32203-7","article-title":"Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017: a systematic analysis for the global burden of disease study 2017","volume":"392","year":"2018","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.vph.2023.107193_bb0015","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1006\/bbrc.1998.9489","article-title":"Isolation and characterization of a novel endogenous peptide ligand for the human APJ receptor","volume":"251","author":"Tatemoto","year":"1998","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"6","key":"10.1016\/j.vph.2023.107193_bb0020","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.devcel.2013.11.002","article-title":"ELABELA: a hormone essential for heart development signals via the apelin receptor","volume":"27","author":"Chng","year":"2013","journal-title":"Dev. Cell"},{"issue":"6172","key":"10.1016\/j.vph.2023.107193_bb0025","doi-asserted-by":"crossref","first-page":"1248636","DOI":"10.1126\/science.1248636","article-title":"Toddler: an embryonic signal that promotes cell movement via Apelin receptors","volume":"343","author":"Pauli","year":"2014","journal-title":"Science"},{"issue":"1\u20132","key":"10.1016\/j.vph.2023.107193_bb0030","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/0378-1119(93)90495-O","article-title":"A human gene that shows identity with the gene encoding the angiotensin receptor is located on chromosome 11","volume":"136","author":"O\u2019Dowd","year":"1993","journal-title":"Gene"},{"issue":"6","key":"10.1016\/j.vph.2023.107193_bb0035","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1139\/bcb-2014-0072","article-title":"The apelin receptor: physiology, pathology, cell signalling, and ligand modulation of a peptide-activated class a GPCR","volume":"92","author":"Chapman","year":"2014","journal-title":"Biochem. Cell Biol."},{"issue":"2","key":"10.1016\/j.vph.2023.107193_bb0040","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.yexcr.2014.08.035","article-title":"Dynamics of apelin receptor\/G protein coupling in living cells","volume":"328","author":"Bai","year":"2014","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.vph.2023.107193_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2020.101629","article-title":"Individual phosphorylation sites at the C-terminus of the apelin receptor play different roles in signal transduction","volume":"36","author":"Chen","year":"2020","journal-title":"Redox Biol."},{"issue":"1","key":"10.1016\/j.vph.2023.107193_bb0050","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1002\/j.2040-4603.2018.tb00012.x","article-title":"Apelinergic system structure and function","volume":"8","author":"Shin","year":"2017","journal-title":"Compr. Physiol."},{"issue":"5","key":"10.1016\/j.vph.2023.107193_bb0055","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1097\/MNH.0000000000000241","article-title":"Apelin-13 in blood pressure regulation and cardiovascular disease","volume":"25","author":"Yamaleyeva","year":"2016","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"issue":"7411","key":"10.1016\/j.vph.2023.107193_bb0060","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1038\/nature11263","article-title":"APJ acts as a dual receptor in cardiac hypertrophy","volume":"488","author":"Scimia","year":"2012","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.vph.2023.107193_bb0065","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/HJH.0000000000002591","article-title":"The Elabela in hypertension, cardiovascular disease, renal disease, and preeclampsia: an update","volume":"39","author":"Xu","year":"2021","journal-title":"J. Hypertens."},{"issue":"9","key":"10.1016\/j.vph.2023.107193_bb0070","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1016\/j.celrep.2017.08.014","article-title":"Loss of Apela peptide in mice causes low penetrance embryonic lethality and defects in early mesodermal derivatives","volume":"20","author":"Freyer","year":"2017","journal-title":"Cell Rep."},{"issue":"6352","key":"10.1016\/j.vph.2023.107193_bb0075","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1126\/science.aam6607","article-title":"ELABELA deficiency promotes preeclampsia and cardiovascular malformations in mice","volume":"357","author":"Ho","year":"2017","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.vph.2023.107193_bb0080","doi-asserted-by":"crossref","first-page":"7989","DOI":"10.1096\/fj.201903029R","article-title":"Elabela\/Toddler and apelin bind differently to the apelin receptor","volume":"34","author":"Couvineau","year":"2020","journal-title":"FASEB J."},{"issue":"7","key":"10.1016\/j.vph.2023.107193_bb0085","doi-asserted-by":"crossref","first-page":"2962","DOI":"10.1021\/acs.jmedchem.5b01549","article-title":"Discovery and structure-activity relationship of a bioactive fragment of ELABELA that modulates vascular and cardiac functions","volume":"59","author":"Murza","year":"2016","journal-title":"J. Med. Chem."},{"issue":"1","key":"10.1016\/j.vph.2023.107193_bb0090","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1021\/acs.jmedchem.0c01547","article-title":"Structure-activity relationship and bioactivity of short analogues of ELABELA as agonists of the Apelin receptor","volume":"64","author":"Tr\u00e2n","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.vph.2023.107193_bb0095","doi-asserted-by":"crossref","first-page":"630548","DOI":"10.3389\/fphar.2021.630548","article-title":"The effects of Apelin and Elabela ligands on Apelin receptor distinct signaling profiles","volume":"12","author":"Jiang","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"30","key":"10.1016\/j.vph.2023.107193_bb0100","doi-asserted-by":"crossref","first-page":"18261","DOI":"10.1074\/jbc.M115.648238","article-title":"Apela regulates fluid homeostasis by binding to the APJ receptor to activate Gi signaling","volume":"290","author":"Deng","year":"2015","journal-title":"J. Biol. Chem."},{"issue":"11","key":"10.1016\/j.vph.2023.107193_bb0105","doi-asserted-by":"crossref","first-page":"e1139","DOI":"10.1097\/CCM.0000000000002639","article-title":"ELABELA improves cardio-renal outcome in fatal experimental septic shock","volume":"45","author":"Coquerel","year":"2017","journal-title":"Crit. Care Med."},{"issue":"12","key":"10.1016\/j.vph.2023.107193_bb0110","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1161\/CIRCULATIONAHA.116.023218","article-title":"Elabela\/Toddler is an endogenous agonist of the Apelin APJ receptor in the adult cardiovascular system, and exogenous administration of the peptide compensates for the downregulation of its expression in pulmonary arterial hypertension","volume":"135","author":"Yang","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.vph.2023.107193_bb0115","doi-asserted-by":"crossref","first-page":"709467","DOI":"10.3389\/fphar.2021.709467","article-title":"Elabela protects spontaneously hypertensive rats from hypertension and cardiorenal dysfunctions exacerbated by dietary high-salt intake","volume":"12","author":"Sainsily","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.vph.2023.107193_bb0120","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.06726","article-title":"The hormonal peptide Elabela guides angioblasts to the midline during vasculogenesis","volume":"4","author":"Helker","year":"2015","journal-title":"Elife"},{"issue":"6","key":"10.1016\/j.vph.2023.107193_bb0125","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.devcel.2017.08.008","article-title":"Alternative progenitor cells compensate to rebuild the coronary vasculature in Elabela- and Apj-deficient hearts","volume":"42","author":"Sharma","year":"2017","journal-title":"Dev. Cell"},{"key":"10.1016\/j.vph.2023.107193_bb0130","doi-asserted-by":"crossref","first-page":"8170","DOI":"10.1038\/srep08170","article-title":"Elabela-apelin receptor signaling pathway is functional in mammalian systems","volume":"5","author":"Wang","year":"2015","journal-title":"Sci. Rep."},{"issue":"12","key":"10.1016\/j.vph.2023.107193_bb0135","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1111\/1440-1681.13382","article-title":"ELABELA improves endothelial cell function via the ELA-APJ axis by activating the PI3K\/Akt signalling pathway in HUVECs and EA.hy926 cells","volume":"47","author":"Wang","year":"2020","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"issue":"5","key":"10.1016\/j.vph.2023.107193_bb0140","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202101785RRR","article-title":"Elabela promotes the retinal angiogenesis by inhibiting ferroptosis during the vaso-obliteration phase in mouse oxygen-induced retinopathy model","volume":"36","author":"Wang","year":"2022","journal-title":"FASEB J."},{"key":"10.1016\/j.vph.2023.107193_bb0145","article-title":"Elabela blunts doxorubicin-induced oxidative stress and ferroptosis in rat aortic adventitial fibroblasts by activating the KLF15\/GPX4 signaling","author":"Zhang","year":"2022","journal-title":"Cell Stress Chaperones"},{"issue":"3","key":"10.1016\/j.vph.2023.107193_bb0150","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.cardiores.2007.02.002","article-title":"Apelin modulates aortic vascular tone via endothelial nitric oxide synthase phosphorylation pathway in diabetic mice","volume":"74","author":"Zhong","year":"2007","journal-title":"Cardiovasc. Res."},{"issue":"3","key":"10.1016\/j.vph.2023.107193_bb0155","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1161\/HYPERTENSIONAHA.109.134619","article-title":"[Pyr1]apelin-13 identified as the predominant apelin isoform in the human heart: vasoactive mechanisms and inotropic action in disease","volume":"54","author":"Maguire","year":"2009","journal-title":"Hypertension"},{"issue":"6","key":"10.1016\/j.vph.2023.107193_bb0160","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1038\/sj.bjp.0703939","article-title":"[(125)I]-(Pyr(1))Apelin-13 is a novel radioligand for localizing the APJ orphan receptor in human and rat tissues with evidence for a vasoconstrictor role in man","volume":"132","author":"Katugampola","year":"2001","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.vph.2023.107193_bb0165","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.avsg.2022.04.033","article-title":"Vascular functional effect mechanisms of Elabela in rat thoracic aorta","volume":"84","author":"Sahinturk","year":"2022","journal-title":"Ann. Vasc. Surg."},{"issue":"1","key":"10.1016\/j.vph.2023.107193_bb0170","doi-asserted-by":"crossref","first-page":"18","DOI":"10.5606\/tgkdc.dergisi.2022.22756","article-title":"The role of potassium channels on vasorelaxant effects of elabela in rat thoracic aorta","volume":"30","author":"\u015eahint\u00fcrk","year":"2022","journal-title":"Turk Gogus Kalp Damar Cerrahisi Derg"},{"key":"10.1016\/j.vph.2023.107193_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.prostaglandins.2023.106735","article-title":"Elabela relaxes rat pulmonary artery and trachea via BKCa, KV, and KATP channels","volume":"167","author":"Sahinturk","year":"2023","journal-title":"Prostaglandins Other Lipid Mediat."},{"issue":"3","key":"10.1016\/j.vph.2023.107193_bb0180","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.devcel.2007.01.012","article-title":"The g protein-coupled receptor agtrl1b regulates early development of myocardial progenitors","volume":"12","author":"Scott","year":"2007","journal-title":"Dev. Cell"},{"issue":"37","key":"10.1016\/j.vph.2023.107193_bb0185","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.add2488","article-title":"A self-generated Toddler gradient guides mesodermal cell migration","volume":"8","author":"Stock","year":"2022","journal-title":"Sci. Adv."},{"key":"10.1016\/j.vph.2023.107193_bb0190","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.22626","article-title":"Toddler signaling regulates mesodermal cell migration downstream of nodal signaling","volume":"6","author":"Norris","year":"2017","journal-title":"Elife"},{"issue":"4","key":"10.1016\/j.vph.2023.107193_bb0195","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.stem.2015.08.010","article-title":"ELABELA is an endogenous growth factor that sustains hESC self-renewal via the PI3K\/AKT pathway","volume":"17","author":"Ho","year":"2015","journal-title":"Cell Stem Cell"},{"issue":"6","key":"10.1016\/j.vph.2023.107193_bb0200","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.stem.2015.04.002","article-title":"An Apela RNA-containing negative feedback loop regulates p53-mediated apoptosis in embryonic stem cells","volume":"16","author":"Li","year":"2015","journal-title":"Cell Stem Cell"},{"issue":"2","key":"10.1016\/j.vph.2023.107193_bb0205","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1007\/s12010-019-03012-2","article-title":"Apela promotes cardiomyocyte differentiation from transgenic human embryonic stem cell lines","volume":"189","author":"Wang","year":"2019","journal-title":"Appl. Biochem. Biotechnol."},{"issue":"2","key":"10.1016\/j.vph.2023.107193_bb0210","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.atherosclerosis.2014.04.029","article-title":"Relationship between plasma apelin level and coronary collateral circulation","volume":"235","author":"Akboga","year":"2014","journal-title":"Atherosclerosis"},{"issue":"3","key":"10.1016\/j.vph.2023.107193_bb0215","doi-asserted-by":"crossref","first-page":"12891","DOI":"10.1111\/eci.12891","article-title":"Apelin-13 treatment enhances the stability of atherosclerotic plaques","volume":"48","author":"Fraga-Silva","year":"2018","journal-title":"Eur. J. Clin. Investig."},{"issue":"2","key":"10.1016\/j.vph.2023.107193_bb0220","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.atherosclerosis.2012.12.002","article-title":"Apelin-13 increases expression of ATP-binding cassette transporter A1 via activating protein kinase C \u03b1 signaling in THP-1 macrophage-derived foam cells","volume":"226","author":"Liu","year":"2013","journal-title":"Atherosclerosis"},{"issue":"11","key":"10.1016\/j.vph.2023.107193_bb0225","first-page":"674","article-title":"Plasma levels of Elabela are associated with coronary angiographic severity in patients with acute coronary syndrome","volume":"17","author":"Du","year":"2020","journal-title":"J. Geriatr. Cardiol."},{"issue":"19","key":"10.1016\/j.vph.2023.107193_bb0230","doi-asserted-by":"crossref","first-page":"4420","DOI":"10.3390\/jcm10194420","article-title":"Plasma levels of Apelinergic system components in patients with chronic and acute coronary syndromes-a pilot study","volume":"10","author":"Diakowska","year":"2021","journal-title":"J. Clin. Med."},{"issue":"3","key":"10.1016\/j.vph.2023.107193_bb0235","first-page":"503","article-title":"Association between serum Elabela levels and chronic totally occlusion in patients with stable angina pectoris","volume":"117","author":"Yavuz","year":"2021","journal-title":"Arq. Bras. Cardiol."},{"issue":"5","key":"10.1016\/j.vph.2023.107193_bb0240","first-page":"330","article-title":"Elabela as a novel marker: well-correlated with WIfI amputation risk score in lower extremity arterial disease patients","volume":"25","author":"Kaplan","year":"2021","journal-title":"Anatol. J. Cardiol."},{"issue":"8","key":"10.1016\/j.vph.2023.107193_bb0245","doi-asserted-by":"crossref","first-page":"623","DOI":"10.2217\/bmm-2021-0865","article-title":"Association of serum elabela levels with carotid artery stenosis in patients with non-cardioembolic ischemic stroke","volume":"16","author":"Dindas","year":"2022","journal-title":"Biomark. Med"},{"key":"10.1016\/j.vph.2023.107193_bb0250","doi-asserted-by":"crossref","DOI":"10.1007\/s40292-022-00554-1","article-title":"A novel peptide Elabela is associated with hypertension-related subclinical atherosclerosis","author":"Hendrianus","year":"2022","journal-title":"High Blood Press. Cardiovasc. Prev."},{"key":"10.1016\/j.vph.2023.107193_bb0255","doi-asserted-by":"crossref","first-page":"173374","DOI":"10.1016\/j.ejphar.2020.173374","article-title":"MicroRNA-122 aggravates angiotensin II-mediated apoptosis and autophagy imbalance in rat aortic adventitial fibroblasts via the modulation of SIRT6-elabela-ACE2 signaling","volume":"883","author":"Song","year":"2020","journal-title":"Eur. J. Pharmacol."},{"issue":"5","key":"10.1016\/j.vph.2023.107193_bb0260","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1007\/s10735-021-10011-3","article-title":"Elabela prevents angiotensin II-induced apoptosis and inflammation in rat aortic adventitial fibroblasts via the activation of FGF21-ACE2 signaling","volume":"52","author":"Song","year":"2021","journal-title":"J. Mol. Histol."},{"issue":"10","key":"10.1016\/j.vph.2023.107193_bb0265","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.1038\/s41401-022-00875-w","article-title":"Chronic infusion of ELABELA alleviates vascular remodeling in spontaneously hypertensive rats via anti-inflammatory, anti-oxidative and anti-proliferative effects","volume":"43","author":"Ye","year":"2022","journal-title":"Acta Pharmacol. Sin."},{"issue":"1","key":"10.1016\/j.vph.2023.107193_bb0270","doi-asserted-by":"crossref","first-page":"H124","DOI":"10.1152\/ajpheart.00449.2019","article-title":"Exacerbated pressor and sympathoexcitatory effects of central Elabela in spontaneously hypertensive rats","volume":"318","author":"Geng","year":"2020","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"43","key":"10.1016\/j.vph.2023.107193_bb0275","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000017645","article-title":"Increased Elabela levels in the acute ST segment elevation myocardial infarction patients","volume":"98","author":"D\u00f6nmez","year":"2019","journal-title":"Medicine (Baltimore)"},{"issue":"4","key":"10.1016\/j.vph.2023.107193_bb0280","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1536\/ihj.20-817","article-title":"Plasma level of Elabela in patients with coronary heart disease and its correlation with the disease classification","volume":"62","author":"Tian","year":"2021","journal-title":"Int. Heart J."},{"issue":"5","key":"10.1016\/j.vph.2023.107193_bb0285","doi-asserted-by":"crossref","first-page":"683","DOI":"10.21470\/1678-9741-2019-0461","article-title":"Serum Elabela level significantly increased in patients with complete heart block","volume":"35","author":"Acele","year":"2020","journal-title":"Braz. J. Cardiovasc. Surg."},{"key":"10.1016\/j.vph.2023.107193_bb0290","doi-asserted-by":"crossref","first-page":"638468","DOI":"10.3389\/fcvm.2021.638468","article-title":"Lower plasma Elabela levels in hypertensive patients with heart failure predict the occurrence of major adverse cardiac events: a preliminary study","volume":"8","author":"Ma","year":"2021","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/j.vph.2023.107193_bb0295","doi-asserted-by":"crossref","first-page":"581848","DOI":"10.3389\/fcvm.2020.581848","article-title":"Elabela: a novel biomarker for right ventricular pressure overload in children with pulmonary stenosis or pulmonary atresia with intact ventricular septum","volume":"7","author":"Wang","year":"2020","journal-title":"Front. Cardiovasc. Med."},{"issue":"12","key":"10.1016\/j.vph.2023.107193_bb0300","doi-asserted-by":"crossref","first-page":"6876","DOI":"10.21037\/jtd-21-1728","article-title":"ELABELA acts as a protective biomarker in patients with atrial fibrillation","volume":"13","author":"Cui","year":"2021","journal-title":"J. Thorac. Dis."},{"issue":"1","key":"10.1016\/j.vph.2023.107193_bb0305","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1186\/s12872-021-02197-x","article-title":"Declined ELABELA plasma levels in hypertension patients with atrial fibrillation: a case control study","volume":"21","author":"Ma","year":"2021","journal-title":"BMC Cardiovasc. Disord."},{"issue":"3","key":"10.1016\/j.vph.2023.107193_bb0310","doi-asserted-by":"crossref","DOI":"10.1111\/jpi.12471","article-title":"Protective role of melatonin in cardiac ischemia-reperfusion injury: from pathogenesis to targeted therapy","volume":"64","author":"Zhou","year":"2018","journal-title":"J. Pineal Res."},{"issue":"8","key":"10.1016\/j.vph.2023.107193_bb0315","first-page":"4467","article-title":"Elabela alleviates myocardial ischemia reperfusion-induced apoptosis, fibrosis and mitochondrial dysfunction through PI3K\/AKT signaling","volume":"12","author":"Yu","year":"2020","journal-title":"Am. J. Transl. Res."},{"issue":"11","key":"10.1016\/j.vph.2023.107193_bb0320","doi-asserted-by":"crossref","first-page":"10509","DOI":"10.1007\/s11033-022-07818-y","article-title":"ERK\/HIF-1\u03b1\/VEGF pathway: a molecular target of ELABELA (ELA) peptide for attenuating cardiac ischemia-reperfusion injury in rats by promoting angiogenesis","volume":"49","author":"Rakhshan","year":"2022","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.vph.2023.107193_bb0325","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.freeradbiomed.2021.02.040","article-title":"Oxidative stress in cardiac hypertrophy: from molecular mechanisms to novel therapeutic targets","volume":"166","author":"Ramachandra","year":"2021","journal-title":"Free Radic. Biol. Med."},{"issue":"1","key":"10.1016\/j.vph.2023.107193_bb0330","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/jcmm.16052","article-title":"Elabela may regulate SIRT3-mediated inhibition of oxidative stress through Foxo3a deacetylation preventing diabetic-induced myocardial injury","volume":"25","author":"Li","year":"2021","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.vph.2023.107193_bb0335","doi-asserted-by":"crossref","first-page":"873614","DOI":"10.3389\/fphar.2022.873614","article-title":"ELA-11 protects the heart against oxidative stress injury induced apoptosis through ERK\/MAPK and PI3K\/AKT signaling pathways","volume":"13","author":"Wang","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.vph.2023.107193_bb0340","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106186","article-title":"Elabela ameliorates doxorubicin-induced cardiotoxicity by promoting autophagic flux through TFEB pathway","volume":"178","author":"Chen","year":"2022","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.vph.2023.107193_bb0345","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2021.102185","article-title":"Epigallocatechin-3-gallate pretreatment alleviates doxorubicin-induced ferroptosis and cardiotoxicity by upregulating AMPK\u03b12 and activating adaptive autophagy","volume":"48","author":"He","year":"2021","journal-title":"Redox Biol."},{"issue":"3","key":"10.1016\/j.vph.2023.107193_bb0350","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1161\/HYPERTENSIONAHA.118.11125","article-title":"Myocardial remodeling in hypertension","volume":"72","author":"Gonz\u00e1lez","year":"2018","journal-title":"Hypertension"},{"issue":"7","key":"10.1016\/j.vph.2023.107193_bb0355","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1093\/cvr\/cvx061","article-title":"ELABELA-APJ axis protects from pressure overload heart failure and angiotensin II-induced cardiac damage","volume":"113","author":"Sato","year":"2017","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.vph.2023.107193_bb0360","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.freeradbiomed.2022.01.020","article-title":"Elabela alleviates ferroptosis, myocardial remodeling, fibrosis and heart dysfunction in hypertensive mice by modulating the IL-6\/STAT3\/GPX4 signaling","volume":"181","author":"Zhang","year":"2022","journal-title":"Free Radic. Biol. Med."},{"issue":"3","key":"10.1016\/j.vph.2023.107193_bb0365","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1007\/s12265-022-10214-3","article-title":"MicroRNA-122-5p aggravates angiotensin II-mediated myocardial fibrosis and dysfunction in hypertensive rats by regulating the Elabela\/Apelin-APJ and ACE2-GDF15-Porimin signaling","volume":"15","author":"Song","year":"2022","journal-title":"J. Cardiovasc. Transl. Res."},{"issue":"1","key":"10.1016\/j.vph.2023.107193_bb0370","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1007\/s00395-015-0521-6","article-title":"Characterization of apela, a novel endogenous ligand of apelin receptor, in the adult heart","volume":"111","author":"Perj\u00e9s","year":"2016","journal-title":"Basic Res. Cardiol."},{"issue":"18","key":"10.1016\/j.vph.2023.107193_bb0375","doi-asserted-by":"crossref","first-page":"10382","DOI":"10.1111\/jcmm.15651","article-title":"Apela improves cardiac and renal function in mice with acute myocardial infarction","volume":"24","author":"Pan","year":"2020","journal-title":"J. Cell. Mol. Med."},{"issue":"10","key":"10.1016\/j.vph.2023.107193_bb0380","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202101030R","article-title":"Apela inhibits systemic and renal inflammatory reactions in mice with type I cardiorenal syndrome","volume":"35","author":"Jin","year":"2021","journal-title":"FASEB J."},{"issue":"17","key":"10.1016\/j.vph.2023.107193_bb0385","doi-asserted-by":"crossref","first-page":"8537","DOI":"10.1111\/jcmm.16814","article-title":"Elabela gene therapy promotes angiogenesis after myocardial infarction","volume":"25","author":"Jin","year":"2021","journal-title":"J. Cell. Mol. Med."},{"issue":"7","key":"10.1016\/j.vph.2023.107193_bb0390","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1249\/MSS.0000000000003143","article-title":"ELABELA-APJ-Akt\/YAP signaling axis: a novel mechanism of aerobic exercise in cardioprotection of myocardial infarction rats","volume":"55","author":"Xi","year":"2023","journal-title":"Med. Sci. Sports Exerc."},{"key":"10.1016\/j.vph.2023.107193_bb0395","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.ijcard.2019.04.089","article-title":"Recombinant Fc-Elabela fusion protein has extended plasma half-life andmitigates post-infarct heart dysfunction in rats","volume":"292","author":"Xi","year":"2019","journal-title":"Int. J. Cardiol."},{"issue":"3","key":"10.1016\/j.vph.2023.107193_bb0400","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1080\/10641963.2019.1619756","article-title":"Declined circulating Elabela levels in patients with essential hypertension and its association with impaired vascular function: a preliminary study","volume":"42","author":"Li","year":"2020","journal-title":"Clin. Exp. Hypertens."},{"issue":"12","key":"10.1016\/j.vph.2023.107193_bb0405","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.29271\/jcpsp.2021.12.1412","article-title":"Relationship between serum Elabela level and hypertensive nephropathy","volume":"31","author":"Dogan","year":"2021","journal-title":"J. Coll. Physicians Surg. Pak."},{"key":"10.1016\/j.vph.2023.107193_bb0410","doi-asserted-by":"crossref","first-page":"638468","DOI":"10.3389\/fcvm.2021.638468","article-title":"Lower plasma Elabela levels in hypertensive patients with heart failure predict the occurrence of major adverse cardiac events: a preliminary study","volume":"6","author":"Ma","year":"2021","journal-title":"Front. Cardiovasc. Med."},{"issue":"4","key":"10.1016\/j.vph.2023.107193_bb0415","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1620\/tjem.251.255","article-title":"Serum Elabela levels are elevated in patients with hyperthyroidism","volume":"251","author":"Buyuksimsek","year":"2020","journal-title":"Tohoku J. Exp. Med."},{"issue":"8","key":"10.1016\/j.vph.2023.107193_bb0420","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1016\/j.ajpath.2018.04.008","article-title":"ELABELA\/APELA levels are not decreased in the maternal circulation or placenta among women with preeclampsia","volume":"188","author":"Pritchard","year":"2018","journal-title":"Am. J. Pathol."},{"issue":"3","key":"10.1016\/j.vph.2023.107193_bb0425","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.ajog.2018.12.020","article-title":"ELABELA concentration is not decreased in maternal plasma before the onset of preeclampsia","volume":"220","author":"Villie","year":"2019","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"8","key":"10.1016\/j.vph.2023.107193_bb0430","doi-asserted-by":"crossref","first-page":"916","DOI":"10.29271\/jcpsp.2021.08.916","article-title":"Predictive role of first-trimester ELABELA levels for late-onset preeclampsia","volume":"31","author":"Ozgen","year":"2021","journal-title":"J. Coll. Physicians Surg. Pak."},{"key":"10.1016\/j.vph.2023.107193_bb0435","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.preghy.2019.06.007","article-title":"Is ELABELA a reliable biomarker for hypertensive disorders of pregnancy?","volume":"17","author":"Huang","year":"2019","journal-title":"Pregnancy Hypertens."},{"issue":"1","key":"10.1016\/j.vph.2023.107193_bb0440","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1080\/14767058.2018.1484089","article-title":"ELABELA plasma concentrations are increased in women with late-onset preeclampsia","volume":"33","author":"Panaitescu","year":"2020","journal-title":"J. Matern. Fetal Neonatal Med."},{"issue":"7","key":"10.1016\/j.vph.2023.107193_bb0445","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1080\/01443615.2019.1572727","article-title":"Evaluation of elabela, apelin and nitric oxide findings in maternal blood of normal pregnant women, pregnant women with pre-eclampsia, severe pre-eclampsia and umbilical arteries and venules of newborns","volume":"39","author":"Deniz","year":"2019","journal-title":"J. Obstet. Gynaecol."},{"issue":"2","key":"10.1016\/j.vph.2023.107193_bb0450","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1080\/14767058.2020.1716720","article-title":"Maternal circulating concentrations of soluble Fas and Elabela in early- and late-onset preeclampsia","volume":"35","author":"Para","year":"2022","journal-title":"J. Matern. Fetal Neonatal Med."},{"key":"10.1016\/j.vph.2023.107193_bb0455","doi-asserted-by":"crossref","first-page":"2051701","DOI":"10.1155\/2020\/2051701","article-title":"Association between ELABELA serum concentrations in first trimester and pregnancy-induced hypertension","volume":"2020","author":"Ma","year":"2020","journal-title":"Biomed. Res. Int."},{"issue":"5","key":"10.1016\/j.vph.2023.107193_bb0460","doi-asserted-by":"crossref","first-page":"E773","DOI":"10.1152\/ajpendo.00383.2018","article-title":"ELABELA, as a potential diagnostic biomarker of preeclampsia, regulates abnormally shallow placentation via APJ","volume":"316","author":"Zhou","year":"2019","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"issue":"8","key":"10.1016\/j.vph.2023.107193_bb0465","doi-asserted-by":"crossref","DOI":"10.1016\/j.jogoh.2021.102127","article-title":"Circulating levels of Elabela in pregnant women complicated with intrauterine growth restriction","volume":"50","author":"Behram","year":"2021","journal-title":"J. Gynecol. Obstet. Hum. Reprod."},{"key":"10.1016\/j.vph.2023.107193_bb0470","article-title":"Elabela levels in pregnancies with intrauterine growth retardation","author":"Yener","year":"2022","journal-title":"Ginekol. Pol."},{"issue":"6","key":"10.1016\/j.vph.2023.107193_bb0475","doi-asserted-by":"crossref","first-page":"E1218","DOI":"10.1152\/ajpendo.00257.2019","article-title":"ELABELA measurements by commercial ELISA kits require sample extraction","volume":"317","author":"Georgiadou","year":"2019","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"issue":"7","key":"10.1016\/j.vph.2023.107193_bb0480","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202200266R","article-title":"Apela gene therapy alleviates pulmonary hypertension in rats","volume":"36","author":"Hu","year":"2022","journal-title":"FASEB J."},{"issue":"3","key":"10.1016\/j.vph.2023.107193_bb0485","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.1161\/HYP.0000000000000047","article-title":"Salt sensitivity of blood pressure: a scientific statement from the American Heart Association","volume":"68","author":"Elijovich","year":"2016","journal-title":"Hypertension"},{"key":"10.1016\/j.vph.2023.107193_bb0490","series-title":"WHO Guidelines Approved by the Guidelines Review Committee. Guideline: Sodium Intake for Adults and Children","author":"Organization World Health","year":"2012"},{"key":"10.1016\/j.vph.2023.107193_bb0495","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.f1325","article-title":"Effect of longer term modest salt reduction on blood pressure: Cochrane systematic review and meta-analysis of randomised trials","volume":"346","author":"He","year":"2013","journal-title":"BMJ"},{"issue":"5","key":"10.1016\/j.vph.2023.107193_bb0500","doi-asserted-by":"crossref","first-page":"F1122","DOI":"10.1152\/ajprenal.00606.2019","article-title":"ELABELA antagonizes intrarenal renin-angiotensin system to lower blood pressure and protects against renal injury","volume":"318","author":"Xu","year":"2020","journal-title":"Am. J. Physiol. Ren. Physiol."},{"issue":"8","key":"10.1016\/j.vph.2023.107193_bb0505","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1038\/s41419-020-02912-0","article-title":"ELABELA attenuates deoxycorticosterone acetate\/salt-induced hypertension and renal injury by inhibition of NADPH oxidase\/ROS\/NLRP3 inflammasome pathway","volume":"11","author":"Chen","year":"2020","journal-title":"Cell Death Dis."},{"issue":"5","key":"10.1016\/j.vph.2023.107193_bb0510","doi-asserted-by":"crossref","first-page":"349","DOI":"10.2174\/1566523217666161121111906","article-title":"Sustained ELABELA gene therapy in high-salt diet-induced hypertensive rats","volume":"16","author":"Schreiber","year":"2017","journal-title":"Curr. Gene Ther."},{"issue":"47","key":"10.1016\/j.vph.2023.107193_bb0515","doi-asserted-by":"crossref","first-page":"17985","DOI":"10.1073\/pnas.0605545103","article-title":"Angiotensin II causes hypertension and cardiac hypertrophy through its receptors in the kidney","volume":"103","author":"Crowley","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.vph.2023.107193_bb0520","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.placenta.2019.08.077","article-title":"Reduced ELABELA expression attenuates trophoblast invasion through the PI3K\/AKT\/mTOR pathway in early onset preeclampsia","volume":"87","author":"Wang","year":"2019","journal-title":"Placenta"},{"key":"10.1016\/j.vph.2023.107193_bb0525","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.placenta.2021.02.002","article-title":"ELABELA alleviates syncytiotrophoblast hypoxia\/reoxygenation injury and preeclampsia-like symptoms in mice by reducing apoptosis","volume":"106","author":"Ma","year":"2021","journal-title":"Placenta"},{"issue":"1","key":"10.1016\/j.vph.2023.107193_bb0530","doi-asserted-by":"crossref","first-page":"99","DOI":"10.3390\/cells12010099","article-title":"Elabela: negative regulation of ferroptosis in trophoblasts via the ferritinophagy pathway implicated in the pathogenesis of preeclampsia","volume":"12","author":"Yang","year":"2022","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.vph.2023.107193_bb0535","doi-asserted-by":"crossref","first-page":"19077","DOI":"10.1038\/s41598-019-55650-5","article-title":"Peptide hormone ELABELA enhances extravillous trophoblast differentiation, but placenta is not the major source of circulating ELABELA in pregnancy","volume":"9","author":"Georgiadou","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.vph.2023.107193_bb0540","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.preghy.2022.10.005","article-title":"Exposure to higher concentrations of exogenous ELABELA causes HTR-8\/SVneo trophoblast cell dysfunction: a possible pathogenesis of pre-eclampsia","volume":"30","author":"Liu","year":"2022","journal-title":"Pregnancy Hypertens."},{"issue":"11","key":"10.1016\/j.vph.2023.107193_bb0545","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.3390\/genes13112172","article-title":"Distribution, function, and expression of the Apelinergic system in the healthy and diseased mammalian brain","volume":"13","author":"Ivanov","year":"2022","journal-title":"Genes (Basel)"},{"issue":"1\u20132","key":"10.1016\/j.vph.2023.107193_bb0550","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S1566-0702(02)00178-9","article-title":"Site-specific effects of apelin-13 in the rat medulla oblongata on arterial pressure and respiration","volume":"101","author":"Seyedabadi","year":"2002","journal-title":"Auton. Neurosci."},{"key":"10.1016\/j.vph.2023.107193_bb0555","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.brainresbull.2013.05.013","article-title":"Repeated electroacupuncture attenuating of apelin expression and function in the rostral ventrolateral medulla in stress-induced hypertensive rats","volume":"97","author":"Zhang","year":"2013","journal-title":"Brain Res. Bull."},{"issue":"1","key":"10.1016\/j.vph.2023.107193_bb0560","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/apha.12342","article-title":"Apelin-13 and APJ in paraventricular nucleus contribute to hypertension via sympathetic activation and vasopressin release in spontaneously hypertensive rats","volume":"212","author":"Zhang","year":"2014","journal-title":"Acta Physiol (Oxford)"},{"issue":"14","key":"10.1016\/j.vph.2023.107193_bb0565","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1097\/WNR.0000000000000431","article-title":"Central action of ELABELA reduces food intake and activates arginine vasopressin and corticotropin-releasing hormone neurons in the hypothalamic paraventricular nucleus","volume":"26","author":"Santoso","year":"2015","journal-title":"Neuroreport"},{"issue":"7","key":"10.1016\/j.vph.2023.107193_bb0570","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/s41594-022-00797-5","article-title":"Structural insight into apelin receptor-G protein stoichiometry","volume":"29","author":"Yue","year":"2022","journal-title":"Nat. Struct. Mol. Biol."}],"container-title":["Vascular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1537189123000538?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1537189123000538?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T04:07:36Z","timestamp":1778818056000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1537189123000538"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":114,"alternative-id":["S1537189123000538"],"URL":"https:\/\/doi.org\/10.1016\/j.vph.2023.107193","relation":{},"ISSN":["1537-1891"],"issn-type":[{"value":"1537-1891","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cardiovascular aspects of ELABELA: A potential diagnostic biomarker and therapeutic target","name":"articletitle","label":"Article Title"},{"value":"Vascular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vph.2023.107193","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107193"}}